Am J Transplant, Volume 20, Suppl 3 Archives - Page 109 of 223 - ATC Abstracts

2020 American Transplant Congress
Estimating the Potential Pool of Uncontrolled DCD Donors in the United States
B. J. Boyarsky, K. R. Jackson, A. B. Kernodle, J. V. Sakran, J. M. Garonzik Wang, S. E. Ottmann, D. L. Segev
Johns Hopkins, Baltimore, MD
*Purpose: In contrast to donation after brain death (DBD), donation after circulatory death (DCD) involves recovery of organs from people with devastating neurologic injury who…
2020 American Transplant Congress
Impact of Worsening Renal Function While Waiting for Heart Transplantation
A. Kumar¹, C. P. Thomas²
¹Internal Medicine, University of Vermont, Burlington, VT, ²Internal Medicine, University of Iowa, Iowa City, IA
*Purpose: Pre transplant renal function has been shown to be a strong predictor of long term renal as well as patient survival in heart transplant…
2020 American Transplant Congress
Improved Kidney Function Post Lung Transplant with Intravenous Tacrolimus Avoidance
C. Burt¹, A. Feist¹, K. Afshar², L. Awdishu¹, M. Mariski¹, J. Kozuch¹, G. Yung², E. Golts³
¹Pharmacy, UC San Diego Health, San Diego, CA, ²Pulmonology, UC San Diego Health, San Diego, CA, ³Cardiothoracic Surgery, UC San Diego Health, San Diego, CA
*Purpose: Tacrolimus (TAC) poses a dose-dependent risk of acute kidney injury (AKI) as well as chronic kidney disease (CKD) post-transplant. In 2017, our institution’s lung…
2020 American Transplant Congress
Single Center Snapshot Experience of dd-cfDNA in Lung Transplantation
D. Levine, P. Ong, D. De Armond, E. Sako
University of Texas Health San Antonio, San Antonio, TX
*Purpose: Chronic lung allograft dysfunction (CLAD) is the primary etiology of graft failure and associated with poor survival post lung transplantation (LT). Risk factors for…
2020 American Transplant Congress
Type 3 Innate Lymphoid Cells Are Associated with a Successful Intestinal Transplant
J. Kang¹, K. Loh¹, L. Belyayev¹, S. Moturi¹, M. Sadat¹, K. Khan¹, A. Duttargi¹, Y. Gusev², K. Bhuvaneshwar², H. Ressom², J. Hawksworth¹, C. Matsumoto¹, T. Fishbein¹, A. Kroemer¹
¹MedStar Georgetown Transplant Institute, Washington, DC, ²Georgetown University, Washington, DC
*Purpose: Innate lymphoid cells (ILCs) play fundamental roles in mucosal barrier functionality and tissue homeostasis. We hypothesized that protective IL-22-producing NKp44+ILC3 subsets are reduced under…
2020 American Transplant Congress
Acute on Chronic Liver Failure (ACLF) Patients Have a Dynamic and Progressive Clinical Course Until Receiving a Liver Transplant: A 5-Year Study at the National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico
E. Cervantes-Alvarez¹, M. J. Lizardo-Thiebaud¹, E. Alatorre-Arenas¹, O. Mendez-Guerrero¹, S. Yarza-Regalado¹, A. Torre¹, M. Vilatobá², D. Kershenobich¹, C. A. Huang³, N. Navarro-Alvarez¹
¹Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Surgery, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ³Surgery, University of Colorado Anschutz Medical Campus, DENVER, CO
*Purpose: To characterize the clinical course of patients diagnosed with acute on chronic liver failure (ACLF) before undergoing liver transplantation. ACLF is characterized by an…
2020 American Transplant Congress
The Role of Ceria-Nanoparticles in Renal Ischemia Reperfusion Injury Models in Rats
C. T. Chung, H. Ko, H. Kim, H. Mo, A. Han, S. Min, J. Ha
Seoul National University, College of Medicine, Seoul, Korea, Republic of
*Purpose: Preventing ischemia reperfusion injury (IRI) is an important issue in kidney transplantation, significantly related to graft survival. Ceria nanoparticles has antioxidant properties as a…
2020 American Transplant Congress
Long-Term Islet Allo- and Xenograft Survival is Promoted by Immunoglobulin M Immunotherapy
M. Ma, K. Brayman, P. Chhabra
Department of Surgery, University of Virginia Health System, Charlottesville, VA
*Purpose: To investigate if islet allo- and xenotransplant rejection is mitigated by IgM immunotherapy.*Methods: a) New onset diabetic NOD mice (n=14) were treated with IgM…
2020 American Transplant Congress
Can Organ Donor Potential Be Determined from Death Certificates? A Case Report
S. Gunderson, J. Kemink, C. Topp, W. Payne, T. Brown, B. Welsch
LifeSource, Minneapolis, MN
*Purpose: The 12/17/19 CMS proposed rule revises outcome measures for OPOs using CDC Multiple Cause of Death to determine donation potential defined as the number…
2020 American Transplant Congress
Can Mayo Adhesive Probability Score Can Predict an Adherent Perinephric Fat? Analysis in Japanese Healthy Donor for Transplantation Underwent Laparoscopic Donor Nephrectomy
T. Noda, Y. Miyauchi, K. Koyama, Y. Sawada, K. Nishimura, T. Fukumoto, N. Miura, T. Kikugawa, T. Saika
Department of Urology, Ehime University Graduate School of Medicine, Toon, Japan
*Purpose: This study is aimed to evaluate Mayo Adhesive Probability (MAP) score as a predictor of adherent perinephric fat (APF) by analyzing a cohort of…